Success Metrics

Clinical Success Rate
93.3%

Based on 14 completed trials

Completion Rate
93%(14/15)
Active Trials
0(0%)
Results Posted
71%(10 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_4
4
27%
Ph not_applicable
7
47%
Ph phase_2
2
13%
Ph phase_3
2
13%

Phase Distribution

0

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution15 total trials
Phase 2Efficacy & side effects
2(13.3%)
Phase 3Large-scale testing
2(13.3%)
Phase 4Post-market surveillance
4(26.7%)
N/ANon-phased studies
7(46.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.3%

14 of 15 finished

Non-Completion Rate

6.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(14)
Terminated(1)

Detailed Status

Completed14
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
93.3%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (13.3%)
Phase 32 (13.3%)
Phase 44 (26.7%)
N/A7 (46.7%)

Trials by Status

completed1493%
terminated17%

Recent Activity

0 active trials
Showing 5 of 15
completedphase_4

Comparison of the FemoSeal® Arterial Closure Device to Manual Compression After Coronary Angiography

NCT01001663
completednot_applicable

Haemostasis After Venous Access in Atrial Fibrillation Catheter Ablation: The HARNESS Trial

NCT06470555
completednot_applicable

AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID

NCT03193021
completednot_applicable

Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device

NCT03923387
completednot_applicable

Comparison of Percutaneous Closure to Manual Compression for Hemostasis

NCT04180540
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT01001663Phase 4

Comparison of the FemoSeal® Arterial Closure Device to Manual Compression After Coronary Angiography

Completed
NCT06470555Not Applicable

Haemostasis After Venous Access in Atrial Fibrillation Catheter Ablation: The HARNESS Trial

Completed
NCT03193021Not Applicable

AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID

Completed
NCT03923387Not Applicable

Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device

Completed
NCT04180540Not Applicable

Comparison of Percutaneous Closure to Manual Compression for Hemostasis

Completed
NCT02438475Phase 4

The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure

Completed
NCT01297322Not Applicable

RESPECT Trial - (Rapid Extravascular Sealing Via PercutanEous Collagen ImplanT)

Completed
NCT02237430Not Applicable

Randomized Comparison of MynxGrip Vascular Closure Device and Manual Compression for Closure After Femoral Access Angiography. The Closure Devices Used in Every Day Practice Study, CLOSE-UP III Trial

Completed
NCT01911403Not Applicable

AGIR Study: Angio-Seal in Interventional Radiology

Terminated
NCT02094885Phase 4

The Bioseal Vascular Study

Completed
NCT01662856Phase 3

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

Completed
NCT01389375Phase 4

Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial

Completed
NCT00684047Phase 2

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Completed
NCT01244425Phase 2

Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection

Completed
NCT00345631Phase 3

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Completed

All 15 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
15